European Case Law Identifier: | ECLI:EP:BA:2001:T018897.20010208 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 08 February 2001 | ||||||||
Case number: | T 0188/97 | ||||||||
Application number: | 88310922.5 | ||||||||
IPC class: | C12N 15/00 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | NANBV diagnostics and vaccines | ||||||||
Applicant name: | CHIRON CORPORATION, et al | ||||||||
Opponent name: | (4) Dade Behring Marburg GmbH (5) The Research Foundation for Microbial Diseases of Osaka (6) F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Admissibility of the interventions (no) Admissibility of Appellant's II appeal (yes) Main request - added subject-matter (yes) Auxiliary requests A to D - sufficiency of disclosure (no) Auxiliary request E - inventive step (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: | |||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970188eu1.html
Date retrieved: 17 May 2021